Share on StockTwits

Equities Research Analysts’ downgrades for Thursday, July 10th:

Alexion Pharmaceuticals (NASDAQ:ALXN) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. They currently have $173.00 price target on the stock. Zacks’ analyst wrote, “We are reverting to a Neutral recommendation on Alexion as we believe that the stock is fairly valued at current levels. Alexion’s first quarter adjusted earnings of $1.41 per share surpassed the Zacks Consensus Estimate by $0.32 and the year-ago figure by 143%. The company’s revenues jumped 67% in the quarter to $566.6 million. Results were driven by strong Soliris sales for the PNH and aHUS indications. The company also upped its earnings guidance to the range of $4.75 to $4.85 per share. Growth at Alexion is expected to be driven by strong Soliris sales. Alexion expects several product approvals in the coming years. Successful development and commercialization of these candidates will reduce the company’s dependence on Soliris for growth.”

“AmREIT, Inc.” (NASDAQ:AMRE) was downgraded by analysts at Wunderlich from a buy rating to a hold rating. They currently have $22.00 target price on the stock, up from their previous target price of $21.00.

AuRico Gold (TSE:AUQ) was downgraded by analysts at Canaccord Genuity from a buy rating to a hold rating. They currently have C$5.00 price target on the stock.

BioScrip (NASDAQ:BIOS) was downgraded by analysts at Zacks from a neutral rating to an underperform rating. The firm currently has $6.75 target price on the stock. Zacks’ analyst wrote, “Once again, in the first quarter of 2014, BioScrip delivered a poor bottom-line show. Adjusted net loss from continuing operations of $0.17 per share was much wider than the year-ago adjusted loss per share of $0.01. The results also considerably lagged the Zacks Consensus Estimate of a loss of $0.04. The high-margin PBM business witnessed another quarter of massive downfall, impacted by lower discount cards revenue and the termination of a large contract. This also resulted in a decline in gross profit margin. Growing SG&A expenses following the company’s effort to consolidate recent takeovers adds to our concerns. Meanwhile, reimbursement pressure looms as a potent cause of worry. The competitive landscape is also tough with the presence of larger players. With the dearth of any major near-term catalyst, we downgrade the stock to Underperform.”

A M Castle and (NYSE:CAS) was downgraded by analysts at TheStreet from a hold rating to a sell rating. The analysts wrote, “A M Castle (CAS) has been downgraded by TheStreet Ratings from hold to sell. The company’s weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, poor profit margins and generally disappointing historical performance in the stock itself.”

Copper Mountain Mining Co.. (TSE:CUM) was downgraded by analysts at Mackie from a buy rating to a hold rating. They currently have C$3.10 target price on the stock, up from their previous target price of C$2.70.

Eldorado Gold Corp (TSE:ELD) was downgraded by analysts at Canaccord Genuity from a buy rating to a hold rating. The firm currently has C$9.00 target price on the stock.

E TRADE Financial (NASDAQ:ETFC) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. They currently have $23.00 target price on the stock. Zacks’ analyst wrote, “We have downgraded our long-term recommendation on E*TRADE to Neutral based on reduction in daily average revenue trades (DARTs) in the first 2 months of the second quarter. However, first-quarter 2014 earnings came significantly above the Zacks Consensus Estimate as well as the prior-year quarter earnings. Results benefited from lower expenses and reduced provisions. As the company completed the sale of its market making business during the quarter, we expect the company’s profitability to improve further in the near term as it aims to focus on core operations. E*TRADE’s initiatives to reduce legacy balance sheet risks look promising. However, it might exert near-term pressure on the margins. Also, we remain concerned owing to the volatile equity markets limiting the growth of DARTs.”

Fidelity & Guaranty Life (NYSE:FGL) was downgraded by analysts at Sandler O’Neill from a buy rating to a hold rating.

Fortuna Silver (TSE:FVI) was downgraded by analysts at Canaccord Genuity from a buy rating to a hold rating. They currently have C$7.00 target price on the stock.

Hi-Crush Partners (NASDAQ:HCLP) was downgraded by analysts at Ladenburg Thalmann from a buy rating to a neutral rating.

Honda Motor Co Ltd (NYSE:HMC) was downgraded by analysts at Nomura from a buy rating to a neutral rating.

Nomura (NYSE:NMR) was downgraded by analysts at Macquarie from an outperform rating to a neutral rating.

Primero Mining Corp (NYSE:PPP) was downgraded by analysts at Canaccord Genuity from a buy rating to a hold rating.

Sk Telecom Corporati (NYSE:SKM) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. They currently have $28.00 target price on the stock.

Sandstorm Gold (CVE:SSL) was downgraded by analysts at Canaccord Genuity from a buy rating to a hold rating.

Tahoe Resources (TSE:THO) was downgraded by analysts at Canaccord Genuity from a buy rating to a hold rating.

Tractor Supply Company (NASDAQ:TSCO) was downgraded by analysts at William Blair from an outperform rating to a market perform rating.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.